13F-HR filed by Logos Global Management LP
Logos Global Management LP filed this 13F-HR for the quarter ended 2024-12-31, filed 2025-02-14, with 47 holding rows worth $854,645,914.
- Accession
- 0001172661-25-001041
- Filer
- CIK 1792126
- Filed
- 2025-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2024
A holdings report, 47 entries on the cover page, a total value of $854,645,914 stated on the cover page (in dollars after the unit check, H1), rows summing to $854,645,914 with VALUE read as dollars as filed, 13F file number 028-20025. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 3,000,000 | $77,100,000 | dollars as filed | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 1,250,000 | $66,925,000 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 1,450,000 | $63,423,000 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 900,000 | $42,336,000 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 875,000 | $37,003,750 | dollars as filed | |
| BIONTECH SE SPONSORED ADS | 09075V102 | ADR | 300,000 | $34,185,000 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 750,000 | $31,537,500 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 12,500,000 | $31,375,000 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 450,000 | $31,068,000 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 3,500,000 | $29,890,000 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 200,000 | $27,300,000 | dollars as filed | |
| DESIGN THERAPEUTICS INC | 25056L103 | COM | 4,217,627 | $26,022,759 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 300,000 | $24,558,000 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 800,000 | $22,256,000 | dollars as filed | |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 175,000 | $21,551,250 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 700,000 | $18,984,000 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 3,208,875 | $18,707,741 | dollars as filed | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 200,000 | $17,444,000 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 1,000,000 | $17,420,000 | dollars as filed | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 500,000 | $15,955,000 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 350,000 | $15,732,500 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 500,000 | $14,380,000 | dollars as filed | |
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 300,000 | $13,590,000 | dollars as filed | |
| ARVINAS INC | 04335A105 | COM | 700,000 | $13,419,000 | dollars as filed | |
| ANNEXON INC | 03589W102 | COM | 2,550,000 | $13,081,500 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 200,000 | $12,680,000 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 500,000 | $11,640,000 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 400,000 | $10,680,000 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 450,000 | $10,602,000 | dollars as filed | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 750,000 | $9,877,500 | dollars as filed | |
| BRIGHT MINDS BIOSCIENCES INC | 10919W405 | COMMON STOCK | 245,000 | $8,824,900 | dollars as filed | |
| Y-mAbs Therapeutics Inc | 984241109 | Common Stock | 1,000,000 | $7,830,000 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 300,000 | $7,431,000 | dollars as filed | |
| GERON CORP | 374163103 | COM | 2,000,000 | $7,080,000 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 2,222,222 | $5,511,111 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 1,250,000 | $5,150,000 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 500,000 | $4,470,000 | dollars as filed | |
| UNICYCIVE THERAPEUTICS INC | 90466Y103 | CMN | 5,078,927 | $4,033,684 | dollars as filed | |
| AEROVATE THERAPEUTICS INC | 008064107 | COM | 1,400,000 | $3,710,000 | dollars as filed | |
| RAPPORT THERAPEUTICS INC COM | 75383L102 | Stock | 208,910 | $3,706,063 | dollars as filed | |
| ATYR PHARMA INC | 002120202 | COM NEW | 1,000,000 | $3,620,000 | dollars as filed | |
| ALLAKOS INC | 01671P100 | COM | 2,900,000 | $3,509,000 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 140,000 | $3,150,000 | dollars as filed | |
| SEPTERNA INC COM | 81734D104 | Stock | 134,202 | $3,073,226 | dollars as filed | |
| ARTIVA BIOTHERAPEUTICS INC | 04317A107 | COM | 145,089 | $1,462,497 | dollars as filed | |
| GLYCOMIMETICS INC | 38000Q102 | COM | 5,400,000 | $1,344,600 | dollars as filed | |
| NUVATION BIO INC | 67080N119 | WARR | 66,666 | $15,333 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001172661-25-001041 | this filing | 2025-02-14 | acceptance time not in the bulk data set |